TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,767,580 | +48.3% | 757,000 | +308.7% | 0.10% | +67.7% |
Q3 2022 | $4,563,000 | +488.8% | 185,200 | +640.8% | 0.06% | +588.9% |
Q4 2021 | $775,000 | -78.7% | 25,000 | -83.3% | 0.01% | -78.6% |
Q3 2021 | $3,638,000 | +94.2% | 150,000 | +16.8% | 0.04% | +75.0% |
Q2 2021 | $1,873,000 | – | 128,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
CM Management, LLC | 60,000 | $875,000 | 0.63% |
Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |